Expresión y significación clínica del pepsinógeno C y la colagenasa-3 en el carcinoma de endometrio

Platz, 1995, Female genital tract cancer, Cancer, 75, 270, 10.1002/1097-0142(19950101)75:1+<270::AID-CNCR2820751312>3.0.CO;2-D Samloff, 1989, Peptic ulcer: the many proteinases of aggression, Gastroenterology, 96, 586, 10.1016/S0016-5085(89)80054-X Díez-Itza, 1993, Expression of pepsinogen C in human breast tumors and correlation with clinopathologic parameters, Br J Cancer, 68, 637, 10.1038/bjc.1993.399 Merino, 2000, Pepsinogen C expression in tumors of extragastric origen, Int J Biol Markers, 15, 165, 10.1177/172460080001500207 Vizoso, 1995, Pepsinogen C is a new prognostic marker in primary breast cancer, J Clin Oncol, 13, 54, 10.1200/JCO.1995.13.1.54 Scorilas, 1999, Immunoenzymatically determined pepsinogen C concentration in breast cytosols: an independent favourable prognosis factor in node-positive patients, Clin Cancer Res, 5, 1778 Balbín, 1996, Hormonal regulation of the human pepsinogen C gene in breast cancer cells, J Biol Chem, 271, 15175, 10.1074/jbc.271.25.15175 Freije, 1994, Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J Biol Chem, 24, 16766, 10.1016/S0021-9258(19)89457-7 Stahle-Bäckdahl, 1997, Collagenase-3 (MMP13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis, Lab Invest, 76, 717 Balbín, 1996, Expression of collagenase-3 in the rat ovary during the ovulatory process, J Endocrinol, 149, 405, 10.1677/joe.0.1490405 Lund, 1999, Functional overlap between two classes of matrix degrading proteases in wound healing, Embo J, 18, 4645, 10.1093/emboj/18.17.4645 Mao, 1999, Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysm and vascular smooth muscle cells in culture, Biochem Biophys Res Commun, 261, 904, 10.1006/bbrc.1999.1142 Mitchell, 1996, Cloning, expression and type II collagenolytic activity if matrix metalloproteinase-13 from human osteoarthritic cartilage, J Clin Invest, 97, 761, 10.1172/JCI118475 Knäuper, 1996, Biochemical characterization of human collagenase-3, J Biol Chem, 271, 1544, 10.1074/jbc.271.3.1544 Ashworth, 1999, Fibrillin degradation by matrix metalloproteinases implications for connective tissue remodeling, Biochem J, 340, 171, 10.1042/0264-6021:3400171 Airola, 1997, Human collagenase-3 is expressed in malignant squamous epithelium of the skin, J Invest Dermatol, 109, 225, 10.1111/1523-1747.ep12319441 Cazorla, 1998, Collagenase-3 overexpression is associated with advanced local extension in human squamous cell carcinomas of the larynx, J Pathol, 186, 144, 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-# Johansson, 1999, Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas, Am J Pathol, 154, 469, 10.1016/S0002-9440(10)65293-5 Uría, 1998, Collagenase-3 expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor, Am J Pathol, 153, 91, 10.1016/S0002-9440(10)65549-6 Airola, 1999, Expression of collagenase-1 and –3 and their ainhibitors TIMP-1 and –3 correlates with the level of invasion in malignant melanomas, Br J Cancer, 80, 733, 10.1038/sj.bjc.6690417 Liotta, 1980, Metastatic potential correlates with enzimatic degradation of basement membrane collagen, Nature, 284, 67, 10.1038/284067a0 Creasman, 1998, Carcinoma of the corpus uteri, J Epidemiol Biostat, 1, 35 Foltmann, 1982, Human Prograstricsin. Analysis of intermediates during activation into gastricsin and determination of the aminoacid sequence of the propart, Eur J Biochem, 128, 63, 10.1111/j.1432-1033.1982.tb06931.x Boström, 2000, Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder, Int J Cancer, 88, 417, 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.0.CO;2-G Young, 1991, Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP, Cancer Res, 51, 3748 Murtha, 1993, Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene, Biochemistry, 32, 6459, 10.1021/bi00076a020 Szecsi, 1995, Cellular origin, complementary deoxyribonucleic acid and N-terminal amino acid sequences of human seminal progastricsin, Biol Reprod, 53, 227, 10.1095/biolreprod53.1.227 Prodi, 1980, Multiple steroid hormone receptors in normal and abnormal human endometrium, J Cancer Res Clin Oncol, 98, 173, 10.1007/BF00405961 Hackenberg, 1996, Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids, J Steroid Biochem Mol, 56, 113, 10.1016/0960-0760(95)00228-6 Zhu, 1997, Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer, Int J Cancer, 72, 574, 10.1002/(SICI)1097-0215(19970807)72:4<574::AID-IJC4>3.0.CO;2-N Rodgers, 1994, Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones, J Clin Invest, 94, 946, 10.1172/JCI117461 Marbaix, 1996, Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation, Hum Reprod, 11, 134, 10.1093/humrep/11.suppl_2.134 Wolf, 1996, Messenger ribonucleic acid levels of collagenase (MMP-13) and matrilisin (MMP-7) in virgin, pregnant and postpartum uterus and cervix of rat, Endocrinology, 137, 5429, 10.1210/en.137.12.5429 Vizoso, 1996 Uría, 1997, Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions, Cancer Res, 57, 4882 Johansson, 1997, Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck, Am J Pathol, 151, 499